Rajesh Suman | Medical pharmacology | Research Excellence Award

Prof. Dr. Rajesh Suman | Medical pharmacology | Research Excellence Award

Hind Institute of Medical Sciences, Sitapur | India

Dr. Rajesh Kumar Suman is a distinguished Professor of Pharmacology with an extensive academic, teaching, and research background in medical sciences. He has over a decade of experience teaching pharmacology to medical, dental, paramedical, and nursing students, and is widely recognized for his commitment to quality education and curriculum development. An accomplished researcher, he has authored more than forty publications in reputed indexed journals and has actively contributed to national and international scientific conferences through invited lectures and oral presentations. His research interests primarily focus on diabetes, metabolic syndrome, cardiovascular pharmacology, and natural DPP-IV inhibitors. Dr. Suman has received prestigious recognition for excellence in scientific presentation and research contributions and has been honored for outstanding original research articles. He is also a prolific author of academic textbooks, having written multiple books and practical manuals in pharmacology for undergraduate and dental students, published by leading national and international publishers. In addition, he has contributed scholarly book chapters with global publishing houses. Dr. Suman has successfully completed certified training in medical education technology and curriculum implementation, reflecting his dedication to innovative teaching practices. He has been actively involved in research projects related to drug utilization, prescription patterns, cost-effectiveness, and rational use of medicines, including funded academic research initiatives.

Citation Metrics (Scopus)

  250
  200
  150
  100
      0

Citations
152

Documents
7

h-index
5

Citations

Documents

h-index


View Scopus Profile View Orcid Profile

Featured Publications


Arjuna (Terminalia arjuna), the Natural Dipeptidyl Peptidase IV Inhibitor, Offers Cardiometabolic Protection

– Book Chapter

Natural dipeptidyl peptidase-IV inhibitor mangiferin mitigates diabetes- and metabolic syndrome-induced changes in experimental rats

– Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy (Journal Article)